Destiny Pharma PLC DTTYF
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- $129.96 Mil
- Volume/Avg
- 153,047 / 149,447
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Destiny Pharma PLC is a clinical-stage biotechnology company which is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. It is involved in developing XF-73 Dermal for the treatment of skin infections of antibiotic-resistant bacteria, XF-73 Nasal for prevention of post-surgical staphylococcal infection, XF Throat for prevention of staphylococcal hospital/ventilator-associated pneumonia infection.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 24
- Website
- https://www.destinypharma.com
Valuation
|
Metric
|
DTTYF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
DTTYF
|
|---|---|
Quick Ratio | 9.48 |
Current Ratio | 9.89 |
Interest Coverage | — |
Quick Ratio
DTTYF
Profitability
|
Metric
|
DTTYF
|
|---|---|
Return on Assets (Normalized) | −49.43% |
Return on Equity (Normalized) | −54.71% |
Return on Invested Capital (Normalized) | −57.36% |
Return on Assets
DTTYF
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Cljrpjxv | Lmzw | $586.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Dlwdghsp | Ynxhm | $115.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Zzdvctfg | Bvdqks | $108.2 Bil | |
MRNA
| Moderna Inc | Xnjbtqnl | Kws | $54.0 Bil | |
ARGX
| argenx SE ADR | Nkqgwdjv | Rysb | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Mgjkptywn | Vkfs | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Sytqjdft | Qgfbtyf | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Bykjtcbvb | Wtyvjk | $14.6 Bil | |
INCY
| Incyte Corp | Gqhhpykvx | Pkfcj | $12.9 Bil | |
RPRX
| Royalty Pharma PLC Class A | Vpsgnccy | Ljwjvm | $12.3 Bil |